abstract |
The present invention relates to pyridopyrimidinone compounds of formula (I), or pharmaceutically acceptable salts thereof, wherein X, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are as defined herein, and compounds comprising such compounds Pharmaceutical compositions as NMDA receptor modulators for the treatment of neurological and psychiatric disorders. |